Hyogo, Japan

Tomoko Nakajima

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 3.0

ph-index = 1


Location History:

  • Kobe, JP (2012)
  • Hyogo, JP (2013)

Company Filing History:


Years Active: 2012-2013

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Tomoko Nakajima: Innovator in Ophthalmic Preparations

Introduction

Tomoko Nakajima is a prominent inventor based in Hyogo, Japan. She has made significant contributions to the field of ophthalmic preparations, holding 2 patents that showcase her innovative spirit and dedication to improving healthcare solutions.

Latest Patents

One of her latest patents is titled "Partial peptide of lacritin." This invention provides a polypeptide containing an amino acid sequence that is a specific partial sequence of lacritin. It is characterized by gyro-modification of N-terminal glutamine. The polypeptide promotes adhesion between a cell and the extracellular matrix and is stable in aqueous solution. Another notable patent is "Percutaneously absorptive ophthalmic preparation comprising olopatadine." This invention offers a percutaneously absorptive preparation for preventing or treating allergic eye disease, which includes olopatadine or a salt thereof as an active ingredient. The method involves applying this preparation to the skin surface, including the eyelid, allowing for effective transfer to the anterior ocular segment.

Career Highlights

Tomoko Nakajima is currently associated with Senju Pharmaceutical Co., Ltd., where she continues to develop innovative solutions in the pharmaceutical industry. Her work focuses on enhancing the efficacy of treatments for eye-related conditions.

Collaborations

She collaborates with notable colleagues, including Takeshi Nakajima and Mitsuyoshi Azuma, contributing to a dynamic research environment that fosters innovation.

Conclusion

Tomoko Nakajima's contributions to ophthalmic preparations reflect her commitment to advancing medical science. Her patents demonstrate her innovative approach to solving complex health issues, particularly in the realm of allergic eye diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…